Desvenlafaxine

Drug Usage Statistics, United States, 2005 - 2015

Number of Prescriptions Over Time (2005 - 2015)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2008 478 -
2009 313  165
2010 214  99
2011 180  34
Year Rank Change
2012 171  9
2013 183  12
2014 200  17
2015 236  36

Patient Out-Of-Pocket Cost Over Time (2005 - 2015)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2015)
Duloxetine 17,890,816
Venlafaxine Hydrochloride 17,109,915
Desvenlafaxine (this drug) 2,225,759

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Khedezla
  • Desvenlafaxine
  • Pristiq
Generic Drug Synonyms and Salts
  • Desvenlafaxine Fumarate
  • Desvenlafaxine Fumarate Monohydrate
  • Desvenlafaxine Succinate
  • Desvenlafaxine

FDA Approval Information

Established Pharmacologic Class (EPC): Serotonin and Norepinephrine Reuptake Inhibitor
Initial FDA approval date: 2/29/2008
First FDA applicant: Rx
First dosage form: Tablet, Extended Release (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2005-2015. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 18.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

©2018 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top
Top